DBS for Depression

Abroad (travel likely)RecruitingPHASE1

Conditions

Treatment Resistant Depression

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Zucker Hillside Hospital, Queens, New York, United States
Contact: Study coordinator (Samantha Gonzalez) · sgonzalez30@northwell.edu · 718-470-4152
Contact: Principal Investigator (Albert J Fenoy, MD)
Contact: Principal Investigator (Miklos Argyelan, MD)

Study leads

Albert J Fenoy, MD
Principal Investigator
Northwell Health

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression

Depression · Major Depressive Disorder · Major Depression

Abroad (travel likely)RecruitingPHASE1

Bethesda, United States

Working Mechanisms and Effectiveness of IV Ketamine-assisted Psychotherapy on Depression in TRD Clients

Treatment Resistant Depression

Abroad (travel likely)Recruiting

Doorn, Netherlands

Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression

Suicide · Depressive Disorder, Treatment-Resistant · Ketamine

Abroad (travel likely)RecruitingPHASE2

Bethesda, United States

A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

Treatment Resistant Depression

Abroad (travel likely)Recruiting

Birmingham, United States · Huntsville, United States